See every side of every news story
Published loading...Updated

Alfred Merz appointed as CEO of ProBioGen - Pharmafile

Summary by pharmafile.com
ProBioGen has announced the appointment of Alfred Merz as its chief executive officer (CEO), effective 1 April 2025. Merz, who was previously chief operating officer (COO) and interim CEO, now assumes leadership of the company. Merz has over 30 years’ worth of experience in manufacturing, operations and strategy development. Before joining ProBioGen 2024, he was […] The post Alfred Merz appointed as CEO of ProBioGen appeared first on Pharmafile.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmafile.com broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.